Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,395 | -26,419 | -10,724 | -27,816 | -22,869 |
| Depreciation Amortization | 451 | 304 | 163 | 936 | 698 |
| Accounts receivable | -908 | 2,449 | 1,090 | 186 | 781 |
| Other Working Capital | -1,937 | 1,616 | 998 | 1,539 | 2,196 |
| Other Operating Activity | 5,148 | 23 | 190 | 1,702 | 1,620 |
| Operating Cash Flow | $-31,641 | $-22,027 | $-8,283 | $-23,453 | $-17,574 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -290 | -290 | -290 | -2,560 | -1,819 |
| Common Stock Issued | N/A | N/A | N/A | 62,151 | 22,939 |
| Other Financing Activity | 0 | 0 | 0 | -4,895 | -1,859 |
| Financing Cash Flow | $-290 | $-290 | $-290 | $54,696 | $19,261 |
| Exchange Rate Effect | 1,845 | 2,600 | 94 | -2,544 | -777 |
| Beginning Cash Position | 54,912 | 54,912 | 54,912 | 26,213 | 26,213 |
| End Cash Position | 24,826 | 35,195 | 46,433 | 54,912 | 27,123 |
| Net Cash Flow | $-30,086 | $-19,717 | $-8,479 | $28,699 | $910 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,641 | -22,027 | -8,283 | -23,453 | -17,574 |
| Free Cash Flow | -31,641 | -22,027 | -8,283 | -23,453 | -17,574 |